| Cat.No. | Name | Information |
|---|---|---|
| M8975 | CWHM-12 | CWHM-12 is a potent inhibitor of αV integrins with IC50 values of 0.2, 0.8, 1.5, and 1.8 nM for αvβ8, αvβ3, αvβ6, and αvβ1, respectively. |
| M9173 | Cilengitide TFA | Cilengitide TFA is a potent integrin inhibitor for αvβ3 and αvβ5 receptor with IC50 of 4.1 nM, 79 nM in cell-free assays respectively. |
| M2042 | Cilengitide | Cilengitide (EMD 121974, NSC 707544) is a selective inhibitor of αvβ3 integrin and αvβ5 integrin with IC50 of 1 nM and 140 nM, respectively. |
| M13754 | OSU-T315 | OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain). |
| M53340 | Gly-Arg-Gly-Asp-Ser TFA | Gly-Arg-Gly-Asp-Ser (TFA) is a pentapeptide that forms the cell-binding domain of a glycoprotein, osteopontin. |
| M53339 | Echistatin | Echistatin, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. |
| M53338 | KGDS | KGDS is synthetic peptides, targeting integrin GPIIb-IIIa located on the membrane of human activated platelets. |
| M53337 | LXW7 | LXW7, a cyclic peptide containing Arg-Gly-Asp (RGD), is an integrin αvβ3 inhibitor. |
| M53336 | Synstatin (92-119) | Synstatin (92-119) is an anti-tumor agent that inhibits angiogenesis and cancer cell invasion. |
| M53335 | RGD-4C | RGD-4C is a arginine-glycine-aspartic acid peptide (ACDCRGDCFC) with integrin binding activity. |
| M53334 | FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro | FITC-Ahx Gly Arg Gly Asp Ser Pro is a GRGDSP coupled to FITC. |
| M53333 | Cyclo(Gly-Arg-Gly-Asp-Ser-Pro) | Cyclo(Gly-Arg-Gly-Asp-Ser-Pro) (c(GRGDSP)) is an RGD-containing inhibitory peptide. |
| M53332 | Cyclo(Arg-Gly-Asp-D-Phe-Val) | Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor. |
| M53331 | Cyclo(Ala-Arg-Gly-Asp-Mamb) | Cyclo(Ala-Arg-Gly-Asp-Mamb) is a selective RGD peptide antagonist and has the potential for Pulmonary arterial hypertension Research. |
| M53330 | Eptifibatide monoacetate | Eptifibatide monoacetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity. |
| M53329 | cRGDfK-thioacetyl ester | cRGDfK-thioacetyl ester is a bioactive polypeptide molecule. |
| M53328 | Lys-Gln-Ala-Gly-Asp-Val | Lys-Gln-Ala-Gly-Asp-Val (KQAGDV) is the six most carboxyl-terminal amino acids in the fibrinogen γ-chain sequence. |
| M53327 | Galacto-RGD | Galacto-RGD is an RGD analogue that can be coupled with the radioactive isotope 18F and used as an integrin α₅β₃ selective tracer. |
| M53326 | RGDSPASSKP | RGDSPASSKP is a RGDS-containing fibronectin decapeptide. |
| M53325 | Batifiban | Batifiban, a cyclic peptide, is a platelet glycoprotein GPⅡb/Ⅲa antagonist, and inhibits platelet aggregation. |
| M53324 | EILEVPST | EILEVPST is a recombinant human fibronectinderived low-molecular-weight peptide fragment. |
| M53323 | LDV-FITC | LDV-FITC, a fluorescent peptide, is a FITC-conjugated LDV peptide. |
| M53322 | REDV | REDV is the minimal active sequence within the CS5 site of the alternatively spliced type III connecting segment (IIICS) region of fibronectin. |
| M53321 | mP6 | mP6 (Myr-FEEERA-OH) is a myristoylated peptide. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
